61 ms·
If you think that's nuts, you should look at Medicare Part D: By the design of the program, the federal government is not permitted to negotiate prices of drug
by EGreg 10y ago
If you think that's nuts, you should look at Medicare Part D:
By the design of the program, the federal government is not permitted to negotiate prices of drugs with the drug companies, as federal agencies do in other programs. The Department of Veterans Affairs, which is allowed to negotiate drug prices and establish a formulary, has been estimated to pay between 40%[27] and 58%[28] less for drugs, on average, than Medicare Part D.
Although generic versions of [frequently prescribed to the elderly] drugs are now available, plans offered by three of the five [exemplar Medicare Part D] insurers currently exclude some or all of these drugs from their formularies.…Further, prices for the generic versions are not substantially lower than their brand-name equivalents. The lowest price for simvastatin (generic Zocor) 20 mg is 706 percent more expensive than the VA price for brand-name Zocor. The lowest price for sertraline HCl (generic Zoloft) is 47 percent more expensive than the VA price for brand-name Zoloft."
— Families USA 2007 "No Bargain: Medicare Drug Plans Deliver High Prices"
Estimating how much money could be saved if Medicare had been allowed to negotiate drug prices, economist Dean Baker gives a "most conservative high-cost scenario" of $332 billion between 2006 and 2013 (approximately $50 billion a year). Economist Joseph Stiglitz in his book entitled The Price of Inequality estimated a "middle-cost scenario" of $563 billion in savings "for the same budget window".[29]:48
Former Congressman Billy Tauzin, R–La., who steered the bill through the House, retired soon after and took a $2 million a year job as president of Pharmaceutical Research and Manufacturers of America (PhRMA), the main industry lobbying group. Medicare boss Thomas Scully, who threatened to fire Medicare Chief Actuary Richard Foster if he reported how much the bill would actually cost, was negotiating for a new job as a pharmaceutical lobbyist as the bill was working through Congress.[30][31] A total of 14 congressional aides quit their jobs to work for the drug and medical lobbies immediately after the bill's passage.[32]
(Wikipedia)
- m_mueller 10y agoAre there reliable estimates on how much lobbying money is being spent, including retirement positions for congressmen? How much of congress could a philantropic billionaire like Warren Buffett buy?
- shostack 10y agoWow taken at face value how did this not cause more of a storm?
- marak830 10y agoHoly fuck. There's corrupt, but that's a new low. How the hell do we let people get away with this.
- refurb 10y agoBy the design of the program, the federal government is not permitted to negotiate prices of drugs with the drug companies Yes, but Medicare Part D is not run by the federal gov't, it's run by private insurers (the gov't just pays them). Private Part D plans negotiate down the cost of drugs all the time. In fact, the actual costs of Part D have consistently come in lower than projected since the start of the program. Private Part D plans get lump sum payments from the gov't to pay for patients. Each Part D plan bids on being a provider. So, when the Part D plan negotiates a lower price on a drug, they can bid lower for their overall plan and the savings get passed onto the gov't. And it's not fair to compare Medicare Part D prices to what the VA pays. The VA is a pretty small slice of the market and there is statutory language about the discounts they must receive. A lot of it isn't even negotiated. And finally, Medicare couldn't negotiate lower prices if it wanted to. Right now, Medicare Part D has a hell of a time excluding a drug from their formulary. They basically can't say "no, patients can't use this drug". If they can't say no, then what leverage do they have over drug companies? The rules on how Medicare can manage their formulary would have to change before they could start negotiating.
- hga 10y agoAnd don't forget that us Medicare Part D "customers" or whatever you want to call us have more than a little skin in the game, especially the ones who'll enter the "donut hole". I'd add that the government "choosing a plan" web site is rather good, give it a list of drugs and it'll tell you what you'll pay next year, modulo changes. It's also not difficult to manipulate it to play what if games, e.g. every once in a while I get a sinus infection, and it takes 30 days of a not so cheap generic antibiotic to be sure to cure it. So I put that drug on and off my list, to make sure it'll be acceptably priced if I have bad luck next year. Displays quality survey data that seems to have some relation to reality, makes enrolling in a new plan a snap, etc. etc.